Silver Nanoparticle-Based Therapy: Can It Be Useful to Combat Multi-Drug Resistant Bacteria?

Area of Science:

• Nanomedicine
• Microbiology
• Toxicology

Background:

• Antibiotic-resistant bacteria, termed "superbugs", pose a significant global health threat.
• The World Health Organization highlights the urgent need for novel therapeutic strategies against these pathogens.
• Silver nanoparticles (AgNPs) are being investigated as a potential alternative to conventional antibiotics.

Purpose of the Study:

• To review the potential of silver nanoparticles (AgNPs) in treating diseases caused by antibiotic-resistant bacteria.
• To explore the mechanisms of action and toxicological profiles of AgNPs.
• To assess the current state of research regarding AgNPs for combating multi-drug resistant bacteria.

Main Methods:

• Literature review focusing on silver nanoparticles and antibiotic-resistant bacteria.
• Analysis of mechanisms of AgNP action against bacteria.
• Review of in vitro and in vivo toxicological studies of AgNPs.

Main Results:

• AgNPs exhibit antibacterial activity against key superbugs like Acinetobacter baumannii, Pseudomonas aeruginosa, and resistant Staphylococcus aureus.
• AgNP toxicity is influenced by factors including dose, size, shape, and electrical charge.
• Mechanisms of action involve disruption of bacterial plasma membranes, DNA replication, enzyme inactivation, and reactive oxygen species (ROS) generation.

Conclusions:

• Silver nanoparticles present a viable therapeutic avenue against multi-drug resistant bacteria.
• Further research is essential to optimize AgNP characteristics and fully understand their toxicological impact before clinical implementation.
• Discrepancies in current research necessitate continued investigation to establish effective and safe AgNP-based therapies.